Sifflet | $18,000,000 | (Jun 24, 2025)
RevelAi Health | $3,100,000 | (Jun 24, 2025)
SWARM Biotactics | $11,591,050 | (Jun 24, 2025)
Certified by Founder
Lodge
Bicara Therapeutics
start up
United States
- Cambridge, Massachusetts
- 07/03/2023
- Series B
- $108,000,000
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy. For more, please visit: bicara.com.
- Industry Biotechnology Research
- Website https://www.bicara.com/
- LinkedIn https://www.linkedin.com/company/bicara-therapeutics/
Veda | $18,000,000 | (Jun 24, 2025)
Meridian | $7,000,000 | (Jun 24, 2025)
Spinwheel | $30,000,000 | (Jun 24, 2025)
Stackup | $4,200,000 | (Jun 24, 2025)
VoiceCare AI | $4,500,000 | (Jun 24, 2025)
YieldClub | $2,500,000 | (Jun 24, 2025)
Steuerboard | $841,106,314 | (Jun 24, 2025)
Botpress | $25,000,000 | (Jun 24, 2025)
Snowcap Compute Inc. | $23,000,000 | (Jun 24, 2025)
Profound | $20,000,000 | (Jun 24, 2025)